{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:35:38Z","timestamp":1791041738406,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00467-014-2956-7","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T08:37:16Z","timestamp":1418200636000},"page":"1903-1908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Gordon Syndrome: a continuing story"],"prefix":"10.1007","volume":"30","author":[{"given":"Kevin M.","family":"O\u2019Shaughnessy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"2956_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5694\/j.1326-5377.1964.tb115766.x","volume":"2","author":"W Paver","year":"1964","unstructured":"Paver W, Pauline G (1964) Hypertension and hyperpotassaemia without renal disease in a young male. Med J Aust 2:305\u2013306","journal-title":"Med J Aust"},{"key":"2956_CR2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imj.1970.19.4.287","volume":"19","author":"RD Gordon","year":"1970","unstructured":"Gordon RD, Geddes RA, Pawsey CG, O\u2019Halloran MW (1970) Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 19:287\u2013294","journal-title":"Australas Ann Med"},{"key":"2956_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00467-012-2206-9","volume":"28","author":"HR Toka","year":"2013","unstructured":"Toka HR, Koshy JM, Hariri A (2013) The molecular basis of blood pressure variation. Pediatr Nephrol 28:387\u2013399","journal-title":"Pediatr Nephrol"},{"key":"2956_CR4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1046\/j.1440-1681.2001.03575.x","volume":"28","author":"JM Achard","year":"2001","unstructured":"Achard JM, Disse-Nicodeme S, Fiquet-Kempf B, Jeunemaitre X (2001) Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome). Clin Exp Pharmacol Physiol 28:1048\u20131052","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2956_CR5","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1210\/jcem.87.7.8449","volume":"87","author":"H Mayan","year":"2002","unstructured":"Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z (2002) Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87:3248\u20133254","journal-title":"J Clin Endocrinol Metab"},{"key":"2956_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/003693308603100114","volume":"31","author":"RD Gordon","year":"1986","unstructured":"Gordon RD, Hodsman GP (1986) The syndrome of hypertension and hyperkalaemia without renal failure: long term correction by thiazide diuretic. Scott Med J 31:43\u201344","journal-title":"Scott Med J"},{"key":"2956_CR7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng0697-202","volume":"16","author":"TA Mansfield","year":"1997","unstructured":"Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen Makelin R, Mayan H, Risch N, Lifton RP (1997) Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31\u201342 and 17p11\u2013q21. Nat Genet 16:202\u2013205","journal-title":"Nat Genet"},{"key":"2956_CR8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.jhh.1000705","volume":"12","author":"KM O\u2019Shaughnessy","year":"1998","unstructured":"O\u2019Shaughnessy KM, Fu B, Johnson A, Gordon RD (1998) Linkage of Gordon\u2019s syndrome to the long arm of chromosome 17 in a region recently linked to familial essential hypertension. J Hum Hypertens 12:675\u2013678","journal-title":"J Hum Hypertens"},{"key":"2956_CR9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1126\/science.1062844","volume":"293","author":"FH Wilson","year":"2001","unstructured":"Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107\u20131112","journal-title":"Science"},{"key":"2956_CR10","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1038\/sj.onc.1204726","volume":"20","author":"F Verissimo","year":"2001","unstructured":"Verissimo F, Jordan P (2001) WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20:5562\u20135569","journal-title":"Oncogene"},{"key":"2956_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/boc.201300069","volume":"106","author":"S Uchida","year":"2014","unstructured":"Uchida S, Sohara E, Rai T, Sasaki S (2014) Regulation of with-no-lysine kinase signaling by Kelch-like proteins. Biol Cell 106:45\u201356","journal-title":"Biol Cell"},{"key":"2956_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/BJ20121903","volume":"45","author":"A Ohta","year":"2013","unstructured":"Ohta A, Schumacher FR, Mehellou Y, Johnson C, Knebel A, Macartney TJ, Wood NT, Alessi DR, Kurz T (2013) The CUL3-KLHL3 E3 ligase complex mutated in Gordon\u2019s hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem J 45:111\u2013122","journal-title":"Biochem J"},{"key":"2956_CR13","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0308434100","volume":"101","author":"KT Kahle","year":"2004","unstructured":"Kahle KT, Gimenez I, Hassan H, Wilson FH, Wong RD, Forbush B, Aronson PS, Lifton RP (2004) WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia. Proc Natl Acad Sci USA 101:2064\u20132069","journal-title":"Proc Natl Acad Sci USA"},{"key":"2956_CR14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.242728499","volume":"100","author":"KA Choate","year":"2003","unstructured":"Choate KA, Kahle KT, Wilson FH, Nelson-Williams C, Lifton RP (2003) WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl\u2013transporting epithelia. Proc Natl Acad Sci USA 100:663\u2013668","journal-title":"Proc Natl Acad Sci USA"},{"key":"2956_CR15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1172\/JCI17443","volume":"111","author":"CL Yang","year":"2003","unstructured":"Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111:1039\u20131045","journal-title":"J Clin Invest"},{"key":"2956_CR16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1073\/pnas.242735399","volume":"100","author":"FH Wilson","year":"2003","unstructured":"Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP (2003) Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 100:680\u2013684","journal-title":"Proc Natl Acad Sci USA"},{"key":"2956_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/01.HYP.0000174326.96918.d6","volume":"46","author":"AP Golbang","year":"2005","unstructured":"Golbang AP, Murthy M, Hamad A, Liu CH, Cope G, Van\u2019t Hoff W, Cuthbert A, O\u2019Shaughnessy KM (2005) A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. Hypertension 46:295\u2013300","journal-title":"Hypertension"},{"key":"2956_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1681\/ASN.2008121275","volume":"21","author":"B Zhou","year":"2010","unstructured":"Zhou B, Zhuang J, Gu D, Wang H, Cebotaru L, Guggino WB, Cai H (2010) WNK4 enhances the degradation of NCC through a Sortilin-mediated lysosomal pathway. J Am Soc Nephrol 21:82\u201392","journal-title":"J Am Soc Nephrol"},{"key":"2956_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/BJ20051180","volume":"391","author":"AC Vitari","year":"2005","unstructured":"Vitari AC, Deak M, Morrice N, Alessi DR (2005) The WNK1 and WNK4 protein kinases that are mutated in Gordon\u2019s hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J 391:17\u201324","journal-title":"Biochem J"},{"key":"2956_CR20","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.2005365","volume":"7","author":"DR Alessi","year":"2014","unstructured":"Alessi DR, Zhang J, Khanna A, Hochdorfer T, Shang Y, Kahle KT (2014) The WNK-SPAK\/OSR1 pathway: master regulator of cation-chloride cotransporters. Sci Signal 7:re3","journal-title":"Sci Signal"},{"key":"2956_CR21","doi-asserted-by":"crossref","first-page":"13347","DOI":"10.1074\/jbc.M113.543710","volume":"289","author":"LL Rosenbaek","year":"2014","unstructured":"Rosenbaek LL, Kortenoeven MLA, Aroankins TS, Fenton RA (2014) Phosphorylation decreases ubiquitylation of the Thiazide-sensitive cotransporter NCC and subsequent clathrin-mediated endocytosis. J Biol Chem 289:13347\u201313361","journal-title":"J Biol Chem"},{"key":"2956_CR22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1139\/Y10-080","volume":"88","author":"M Glover","year":"2010","unstructured":"Glover M, Mercier Zuber A, Figg N, O\u2019Shaughnessy KM (2010) The activity of the thiazide-sensitive Na(+)-Cl(-) cotransporter is regulated by protein phosphatase PP4. Can J Physiol Pharmacol 88:986\u2013995","journal-title":"Can J Physiol Pharmacol"},{"key":"2956_CR23","doi-asserted-by":"crossref","first-page":"28755","DOI":"10.1074\/jbc.M603773200","volume":"281","author":"D Pacheco-Alvarez","year":"2006","unstructured":"Pacheco-Alvarez D, Cristobal PS, Meade P, Moreno E, Vazquez N, Munoz E, Diaz A, Juarez ME, Gimenez I, Gamba G (2006) The Na+:Cl- cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion. J Biol Chem 281:28755\u201328763","journal-title":"J Biol Chem"},{"key":"2956_CR24","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2012070742","volume":"24","author":"S-S Yang","year":"2013","unstructured":"Yang S-S, Fang Y-W, Tseng M-H, Chu P-Y, Yu I-S, Wu H-C, Lin S-W, Chau T, Uchida S, Sasaki S, Lin Y-F, Sytwu H-K, Lin S-H (2013) Phosphorylation regulates NCC stability and transporter activity in vivo. J Am Soc Nephrol 24:1587\u20131597","journal-title":"J Am Soc Nephrol"},{"key":"2956_CR25","author":"M Chavez-Canales","year":"2014","unstructured":"Chavez-Canales M, Zhang C, Soukaseum C, Moreno E, Pacheco-Alvarez D, Vidal-Petiot E, Castaneda-Bueno M, Vazquez N, Rojas-Vega L, Meermeier NP, Rogers S, Jeunemaitre X, Yang CL, Ellison DH, Gamba G, Hadchouel J (2014) WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4. Hypertension. doi: 10.1161\/HYPERTENSIONAHA.114.04036","journal-title":"Hypertension"},{"key":"2956_CR26","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1681\/ASN.2005111224","volume":"17","author":"G Cope","year":"2006","unstructured":"Cope G, Golbang A, Murthy M, Hamad A, Liu CH, Hoff WV, Cuthbert A, O\u2019Shaughnessy KM (2006) WNK1 affects surface expression of the ROMK potassium channel independent of WNK4. J Am Soc Nephrol 17:1867\u20131874","journal-title":"J Am Soc Nephrol"},{"key":"2956_CR27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ng1271","volume":"35","author":"KT Kahle","year":"2003","unstructured":"Kahle KT, Wilson FH, Leng Q, Lalioti MD, O\u2019Connell AD, Dong K, Rapson AK, MacGregor GG, Giebisch G, Hebert SC, Lifton RP (2003) WNK4 regulates the balance between renal NaCl reabsorption and K+\u2009secretion. Nat Genet 35:372\u2013376","journal-title":"Nat Genet"},{"key":"2956_CR28","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.0510609103","volume":"103","author":"A Lazrak","year":"2006","unstructured":"Lazrak A, Liu Z, Huang CL (2006) Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci USA 103:1615\u20131620","journal-title":"Proc Natl Acad Sci USA"},{"key":"2956_CR29","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1073\/pnas.1304230110","volume":"110","author":"E Vidal-Petiot","year":"2013","unstructured":"Vidal-Petiot E, Elvira-Matelot E, Mutig K, Soukaseum C, Baudrie V, Wu S, Cheval L, Huc E, Cambillau M, Bachmann S, Doucet A, Jeunemaitre X, Hadchouel J (2013) WNK1-related familial hyperkalemic hypertension results from an increased expression of L-WNK1 specifically in the distal nephron. Proc Natl Acad Sci USA 110:14366\u201314371","journal-title":"Proc Natl Acad Sci USA"},{"key":"2956_CR30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature10814","volume":"482","author":"LM Boyden","year":"2012","unstructured":"Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Valimaki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98\u2013102","journal-title":"Nature"},{"key":"2956_CR31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/ng.2218","volume":"44","author":"H Louis-Dit-Picard","year":"2012","unstructured":"Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M, Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X (2012) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44:456\u2013460","journal-title":"Nat Genet"},{"key":"2956_CR32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/CS20130326","volume":"126","author":"M Glover","year":"2014","unstructured":"Glover M, Ware JS, Henry A, Wolley M, Walsh R, Wain LV, Xu S, Van\u2019t Hoff WG, Tobin MD, Hall IP, Cook S, Gordon RD, Stowasser M, O\u2019Shaughnessy KM (2014) Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon\u2019s syndrome). Clin Sci (Lond) 126:721\u2013726","journal-title":"Clin Sci (Lond)"},{"key":"2956_CR33","author":"K Susa","year":"2014","unstructured":"Susa K, Sohara E, Rai T, Zeniya M, Mori Y, Mori T, Chiga M, Nomura N, Nishida H, Takahashi D, Isobe K, Inoue Y, Takeishi K, Takeda N, Sasaki S, Uchida S (2014) Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice. Hum Mol Genet. doi: 10.1093\/hmg\/ddu217","journal-title":"Hum Mol Genet"},{"key":"2956_CR34","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/00004872-200111000-00005","volume":"19","author":"S Disse-Nicodeme","year":"2001","unstructured":"Disse-Nicodeme S, Desitter I, Fiquet-Kempf B, Houot AM, Stern N, Delahousse M, Potier J, Ader JL, Jeunemaitre X (2001) Genetic heterogeneity of familial hyperkalaemic hypertension. J Hypertens 19:1957\u20131964","journal-title":"J Hypertens"},{"key":"2956_CR35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","volume":"402","author":"I Barroso","year":"1999","unstructured":"Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O\u2019Rahilly S (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880\u2013883","journal-title":"Nature"},{"key":"2956_CR36","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cmet.2012.08.011","volume":"16","author":"CJ Pelham","year":"2012","unstructured":"Pelham CJ, Ketsawatsomkron P, Groh S, Grobe JL, de Lange WJ, Ibeawuchi SR, Keen HL, Weatherford ET, Faraci FM, Sigmund CD (2012) Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARgamma and RhoA\/Rho-kinase. Cell Metab 16:462\u2013472","journal-title":"Cell Metab"},{"key":"2956_CR37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1073\/pnas.0808358106","volume":"106","author":"Y Wang","year":"2009","unstructured":"Wang Y, O\u2019Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, Shi X, Pan L, Rampersaud E, Shen H, Kim JD, Subramanya AR, Steinle NI, Parsa A, Ober CC, Welling PA, Chakravarti A, Weder AB, Cooper RS, Mitchell BD, Shuldiner AR, Chang YP (2009) Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 106:226\u2013231","journal-title":"Proc Natl Acad Sci USA"},{"issue":"334","key":"2956_CR38","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.2005365","volume":"7","author":"DR Alessi","year":"2014","unstructured":"Alessi DR, Zhang J, Khanna A, Hochd\u00f6rfer T, Shang Y, Kahle KT (2014) The WNK-SPAK\/OSR1 pathway: master regulator of cation-chloride cotransporters. Sci Signal 7(334):re3","journal-title":"Sci Signal"},{"key":"2956_CR39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/1440-1681.12108","volume":"40","author":"K Siew","year":"2013","unstructured":"Siew K, O\u2019Shaughnessy KM (2013) Extrarenal roles of the with-no-lysine[K] kinases (WNKs). Clin Exp Pharmacol Physiol 40:885\u2013894","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2956_CR40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/BJ20130597","volume":"455","author":"T Mori","year":"2013","unstructured":"Mori T, Kikuchi E, Watanabe Y, Fujii S, Ishigami-Yuasa M, Kagechika H, Sohara E, Rai T, Sasaki S, Uchida S (2013) Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy. Biochem J 455:339\u2013345","journal-title":"Biochem J"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2956-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2956-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2956-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T19:08:30Z","timestamp":1598555310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2956-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["2956"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2956-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,11]]}}}